Open calls · Research grant · Medicine
Expanded Surveillance for Pediatric Infectious Diseases
Centers for Disease Control and Prevention · Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases · RFA-IP-27-035
Deadlines
- 31 Dec 2026 Estimated deadline in 50 days
Time of day: 11:59 pm ET.
Who can apply
- Where the work is done
- United States
- Who applies
- An organisation
Money
- Per project
- $850k–$1.1M per project
- Total budget
- $40M
- Expected awards
- 7
About the call
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.
In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.
Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.
This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.
Component A – Core Component (Required)
• Support inpatient and emergency department pediatric surveillance
• Follow the standardized protocol established by CDC
Optional Components
• Component B: Support outpatient pediatric surveillance
• Component C: Study immune response and infection
• Component D: Study immune response and immunization
Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.
Findings of this NOFO will:
• Improve best practices for diagnosis and treatment protocols
• Inform prevention product recommendations
• Guide public health strategies
• Reduce viral illness-associated hospitalizations and healthcare utilization among children
Text from the funder (US federal government, public domain).
We sort calls into fields, career stages and countries automatically. Always check the conditions on the funder’s page before you apply.
Discussion
Applying too? Looking for partners? Ask here.
